Boston Medical Center quietly transfers ownership in infectious-disease lab
Boston Medical Center and Boston University are carrying out an agreement that has enabled the hospital to sell its ownership stake in the National Emerging Infectious Diseases Laboratory, which they partnered to develop in 2003. Completed in 2009, it has failed to operate at full capacity in the interim due to opposition among neighborhood groups concerned about the research center's plans to work with some of the deadliest microbes and viruses in the world. Boston Medical Center sought an exit from the project in May 2010 and formally "withdrew from further participation" in the disease laboratory a year later, according to recent financial filings. The hospital's exit plan required Boston University to repay BMC its initial $29.1 million investment in the laboratory over a five-year span.
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- CA Powers Up $80M HIE to 'Create Value in the Data'
- TJC Warns Hospitals of Deadly Medical Tubing Mistakes
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- 3 Traits Personality Assessments Can't Reveal
- The secret committee behind our soaring healthcare costs